Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- ChecktodayChange DetectedThe study has transitioned from a recruiting status to an active status, indicating that patient recruitment has concluded. Additionally, the study's timeline has been updated with new dates for the primary database lock and the open-label extension period.SummaryDifference46%
- Check7 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check14 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check36 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check65 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.